Heart disease drug could be used to treat diabetic macular edema

by: Jack Woodfield
New research shows that Darapladib, a heart disease drug, could actually be used treat diabetic macular edema.
Scientists at Queen’s University, Belfast and University College London (UCL) have found that the drug could reduce the need for injections, which is what diabetic macular edema patients are normally treated with.
Diabetic macular edema occurs in roughly seven per cent of patients with diabetes, who may have to be injected directly in to the eye every four to six weeks with anti-VEGF drugs (anti-vascular endothelial growth factor). But the tablet version of Darapladib could limit the need for these injections.
The breakthrough in this research occurred when scientists discovered that Daraplabib inhibited an enzyme, known as Lp-PLA2, which is found in people with diabetes. This enzyme causes blood vessel leakage in the eye, which results in retina swelling and vision loss.
Darapladib was originally developed to treat cardiovascular disease, but researchers are now planning a clinical trial, in partnership with drugs firm GlaxoSmithKline, to see if the drug could provide an alternative treatment for diabetic-related blindness……
Read more: http://www.diabetes.co.uk/news/2016/jun/heart-disease-drug-could-be-used-to-treat-diabetic-macular-edema-91366289.html
Source: Diabetes UK